Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lip Augmentation with Hyaluronic Acid Filler in Fitzpatrick Skin Type V-VI
NCT05730543Phase 3Completed
- Sponsor
- DeNova Research
- Start
- Nov 2022
- Primary completion
- Apr 2023
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Juvederm Ultra, sponsored by DeNova Research. Primary endpoints: Lip size at 1 month and Satisfaction level at 1 month. Started Nov 2022; status: completed.
02
Drugs
Juvederm Ultra
Beyond the preview
Go deeper on NCT05730543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05730543.